What Did We Really Earn? Rethinking Margin Optimization in European Pharma

Watch the webinar on demand and discover how leading pharmaceutical companies are gaining greater visibility into true net revenue and profitability. 

As pricing pressures continue to intensify across Europe, pharmaceutical companies face a critical challenge:

What did we really earn?

In today’s complex market environment, profitability is no longer determined by list price alone. Rebates, tenders, contracting agreements, reimbursement mechanisms, and settlement processes all impact the revenue ultimately retained. As a result, the revenue you book is often very different from the revenue you keep.

Understanding this difference has become essential for making informed pricing, market access, and commercial decisions.

In this on-demand webinar, industry experts explore why Gross-to-Net (GTN) is evolving from a traditional finance function into a strategic capability that helps pharmaceutical companies protect margins, improve forecasting accuracy, and drive profitable growth.

What You'll Learn

• Why Gross-to-Net has become a critical lever for margin optimization in European pharma
• Why list price is only the starting point—and why profitability is won or lost at the net revenue level
• Where margin leakage typically occurs across pricing, contracting, tenders, rebates, reimbursement, and settlement processes
• How leading pharmaceutical companies use forecasting, scenario modeling, and advanced analytics to evaluate the financial impact of commercial decisions before execution
• How Vistex helps connect pricing, contracting, market access, forecasting, and settlement processes to provide greater visibility into true net revenue and profitability

Why Watch?

The question is no longer simply, "What did we earn?"

The organizations that can answer that question with confidence are best positioned to:

• Protect and optimize margins
• Improve forecasting accuracy
• Increase visibility into commercial performance
• Make more profitable pricing and market access decisions
• Navigate an increasingly complex European pharmaceutical landscape

Access the Recording

Complete the form to watch the webinar on demand and learn how greater transparency into net revenue can help your organization improve profitability and make smarter commercial decisions.

Watch Now